Back
SPDR® MSCI ACWI Climate Paris AlignedETF Vs. Dyne Therapeutics Industry Stock Comparison
Buy
63
NZAC
SPDR® MSCI ACWI Climate Paris AlignedETF
Last Price:
37.39
Seasonality Move:
4.01%
Sell
46
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Buy
63
SPDR® MSCI ACWI Climate Paris AlignedETF (NZAC)
is a Buy
Is SPDR® MSCI ACWI Climate Paris AlignedETF a Buy, Sell or Hold?
- The current SPDR® MSCI ACWI Climate Paris AlignedETF [NZAC] share price is $37.21. The Score for NZAC is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- NZAC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NZAC Stock Price Chart
What is SPDR® MSCI ACWI Climate Paris AlignedETF's stock price today?
-
The SPDR® MSCI ACWI Climate Paris AlignedETF share price today is $37.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NZAC is experiencing selling pressure, which indicates risk of future bearish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $30.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
NZAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 50.92 | Buy |
| Chaikin Money Flow: | -40391 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.9 - 37.56) | Sell |
| Bollinger Bands (100): | (35.01 - 37.21) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 47.11 | Sell |
| Chaikin Money Flow: | -1019710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.92 - 33.44) | Sell |
| Bollinger Bands (100): | (31.39 - 42.57) | Sell |
NZAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.41 | Sell |
| 20-day SMA: | 37.19 | Buy |
| 50-day SMA: | 36.98 | Buy |
| 200-day SMA: | 34.77 | Buy |
| 8-day EMA: | 37.32 | Sell |
| 20-day EMA: | 37.22 | Sell |
| 50-day EMA: | 36.87 | Buy |
| 200-day EMA: | 34.81 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.77 | Buy |
| 20-day SMA: | 30.55 | Sell |
| 50-day SMA: | 32.55 | Sell |
| 200-day SMA: | 32.11 | Sell |
| 8-day EMA: | 30.26 | Buy |
| 20-day EMA: | 30.69 | Sell |
| 50-day EMA: | 32.85 | Sell |
| 200-day EMA: | 30.82 | Sell |
SPDR® MSCI ACWI Climate Paris AlignedETF Earnings Growth & NZAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.
SPDR® MSCI ACWI Climate Paris AlignedETF Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||